Angiotensin I-converting enzyme inhibitory activity and hypocholesterolemic effect of some fermented tropical legumes in streptozotocin-induced diabetic rats

Original Article
First Online:
Received:
Accepted:

Abstract

Cardiovascular disease (CVD) is the common cause of morbidity and mortality in diabetes. Any antidiabetic management strategy should therefore include the control of CVD risk factors. Thus, this study describes the effect of fermented legume condiment-supplemented diets on lung angiotensin I-converting enzyme (ACE) and lipid profile in streptozotocin (STZ)-induced diabetic rats. Adult male Wistar rats were used for the study and diabetes was induced in them by a single intraperitoneal injection of STZ (35 mg/kg b.w.). After the diabetic status had been confirmed, the animals were randomly divided into six groups consisting of six animals each and were fed with diets supplemented with fermented Bambara groundnut, locust bean, and soybean. The study lasted for 14 days after which the plasma was analyzed for the lipid profile and the rats’ lungs were assayed for ACE activity. Elevated ACE activity, plasma total cholesterol, triglyceride, and LDL-cholesterol showed significant (P < 0.05) reduction in the rats treated with fermented legume condiment-supplemented diets, with a concomitant increase in plasma HDL-cholesterol as compared with the diabetic control. This study therefore concludes that fermented legume condiment-supplemented diets could attenuate diabetes-induced dyslipidemia, a major coronary disease risk factor, in experimental rats. This health benefit of the condiment diets could be associated with their ACE inhibitory and antihypercholesterolemic properties. However, the diet supplemented with fermented locust bean condiment appeared to be the most potent.

Keywords

Angiotensin I-converting enzyme Hypercholesterolemia Dyslipidemia Diabetes mellitus Streptozotocin Legume condiments Phenolics 
This is a preview of subscription content, log in to check access.

Notes

Conflict of interest

The authors declare no conflict of interest.

References

  1. 1.
    Wild S, Rolglic G, Green A, Sicress R, King H. Global prevalence of diabetes. Diabetes Care. 2004;27:1047–53.CrossRefPubMedGoogle Scholar
  2. 2.
    Reasoner CA. Reducing cardiovascular complications of type 2 diabetes by targeting multiple risk factors. J Cardiovasc Pharmacol. 2008;52:136–44.CrossRefGoogle Scholar
  3. 3.
    Farmer JA. Diabetic dyslipidemia and atherosclerosis: evidence from clinical trials. Curr Atheroscler Rep. 2007;9:162–8.CrossRefPubMedGoogle Scholar
  4. 4.
    Akbulut T, Bilsel T, Terzi S, Ciloglu F, Unal-Dayi S, Sayar N, et al. Relationship between ACE gene polymorphism and ischemic chronic heart failure in Turkish population. Eur J Med Res. 2003;8:247–53.PubMedGoogle Scholar
  5. 5.
    Cooper SA, Whaley-Connell A, Habibi J, Wei Y, Lastra G, Manrique CM, et al. Renin–angiotensin–aldosterone system and oxidative stress in cardiovascular insulin resistance. Am J Physiol Heart Circ Physiol. 2007;293(4):H2009–23.CrossRefPubMedGoogle Scholar
  6. 6.
    Chu KY, Leung PS. Angiotensin II in type 2 diabetes mellitus. Curr Protein Pept Sci. 2009;10(1):75–84.CrossRefPubMedGoogle Scholar
  7. 7.
    Hosseini M, Shafiee SM, Baluchnejadmojarad T. Garlic extract reduces serum angiotensin converting enzyme (ACE) activity in nondiabetic and streptozotocin-diabetic rats. Pathophysiology. 2007;14:109–12.CrossRefPubMedGoogle Scholar
  8. 8.
    Itoh H, Mukoyama M, Pratt RE, Gibbons GH, Dzau VJ. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest. 1993;91:2268–74.PubMedCentralCrossRefPubMedGoogle Scholar
  9. 9.
    Sposito AC. Emerging insights into hypertension and dyslipidemia synergies. Eur Heart J Suppl. 2004;6:G8–G12.CrossRefGoogle Scholar
  10. 10.
    Meyer G, Merval R, Tedgui A. Effect of pressure-induced stretch and convection on low-density lipoprotein and albumin uptake in the rabbit aortic wall. Circ Res. 1996;79:532–40.CrossRefPubMedGoogle Scholar
  11. 11.
    Davila MA, Sangronis E, Granito M. Germinated or fermented legumes: food or ingredients of functional food. Arch Latinoam Nutr. 2003;53(4):348–54.PubMedGoogle Scholar
  12. 12.
    Hu FB. Plant-based foods and prevention of cardiovascular disease: an overview. Am J Clin Nutr. 2003;78(3):544S–51S.PubMedGoogle Scholar
  13. 13.
    Zhang JH, Tatsumi E, Ding CH, Li LT. Angiotensin I-converting enzyme inhibitory peptides in douchi, a Chinese traditional fermented soybean product. Food Chem. 2006;98:551–7.CrossRefGoogle Scholar
  14. 14.
    Ademiluyi AO, Oboh G. Phenolic-rich extracts from selected tropical underutilized legumes inhibit α-amylase, α-glucosidase, and angiotensin I converting enzyme in vitro. J Basic Clin Physiol Pharmacol. 2012. doi: 10.1515/JBCPP.2011.005.PubMedGoogle Scholar
  15. 15.
    Omafuvbe BO, Falade OS, Osuntogun BA, Adewusi SRA. Chemical and biochemical changes in African locust bean (Parkia biglobosa) and melon (Citrullus vulgaris) seeds during fermentation to condiments. Pak J Nutr. 2004;3(3):140–5.CrossRefGoogle Scholar
  16. 16.
    Cushman DW, Cheung HS. Spectrophotometric assay and properties of the angiotensin I converting enzyme of rabbit lung. Biochem Pharmacol. 1971;20:1637–48.CrossRefPubMedGoogle Scholar
  17. 17.
    Chu Y, Sun J, Wu X, Liu RH. Antioxidant and antiproliferative activity of common vegetables. J Agric Food Chem. 2002;50:6910–6.CrossRefPubMedGoogle Scholar
  18. 18.
    Krentz AJ. Lipoprotein abnormalities and their consequences for patients with type 2 diabetes. Diabetes Obes Metab. 2003;5:S19–27.CrossRefPubMedGoogle Scholar
  19. 19.
    Temme EH, Vaqn HPG, Schouten EG, Kesteloot H. Effect of a plant sterol-enriched spread on serum lipids and lipoproteins in mildly hypercholesterolaemic subjects. Acta Cardiology. 2002;57:111–5.CrossRefGoogle Scholar
  20. 20.
    Ravi K, Rajasekaran S, Subramanian S. Antihyperlipidemia effect of Eugenia jambolana seed kernel on streptozotocin induced diabetes in rats. Food Chem Toxicol. 2005;43:1433–9.CrossRefPubMedGoogle Scholar
  21. 21.
    Wei S, Ze X, Xiao-Wen H. Study on soybean peptide fermentation and its functions. Food Science and Technology 2005; 4. DOI:CNKI:SUN:ZNGZ.0.2005-06-007Google Scholar
  22. 22.
    Chun J, Kim JS, Kim JH. Enrichment of isoflavone aglycones in soymilk by fermentation with single and mixed cultures of Streptococcus infantarius 12 and Weissella sp. 4. Food Chem. 2008;109(2):278–84.CrossRefPubMedGoogle Scholar
  23. 23.
    Duranti M. Grain legume proteins and nutraceutical properties. Fitoterapia. 2006;77:67–82.CrossRefPubMedGoogle Scholar
  24. 24.
    Fukui K, Tachibana N, Fukuda Y, Takamatsu K, Sugano M. Ethanol washing does not attenuate the hypocholesterolemic potential of soy protein. Nutrition. 2004;20:984–90.CrossRefPubMedGoogle Scholar
  25. 25.
    Kingman SM. The influence of legume seeds on human plasma lipid concentrations. Nutr Res Rev. 1991;4:97–123.CrossRefPubMedGoogle Scholar
  26. 26.
    Manzoni C, Duranti M, Eberini I, Scharnag H, März W, Castiglioni S, et al. Subcellular localization of soybean 7S globulin in HepG2 cells and LDL receptor up-regulation by its α’ constituent subunit. J Nutr. 2003;133:2149–55.PubMedGoogle Scholar
  27. 27.
    Taku K, Umegaki K, Sato Y, Taki Y, Endoh K, Watanabe S. Soy isoflavones lower serum total and LDL cholesterol in humans: a meta-analysis of 11 randomized controlled trials. Am J Clin Nutr. 2007;85:1148–56.PubMedGoogle Scholar
  28. 28.
    Cheik NC, Rossi EA, Guerra RLF, Neuli Maria Tenório NM, Nascimento CM O d, Viana FP, et al. Effects of a ferment soy product on the adipocyte area reduction and dyslipidemia control in hypercholesterolemic adult male rats. Lipids in Health and Disease. 2008;7:50. doi: 10.1186/1476-511X-7-50.PubMedCentralCrossRefPubMedGoogle Scholar
  29. 29.
    Kwon DY, Oh SW, Lee JS, Yang HJ, Lee SH, Lee JH. Amino acid substitution of hypocholesterolemic peptide originated from glycinin hydrolyzate. Food Sci Biotechnol. 2002;11:55–61.Google Scholar
  30. 30.
    Yang HJ, Park S, Pak V, Chung KR. Fermented soybean products and their bioactive compounds. In: Soybean and health 2011; Pp21 – 58.Google Scholar
  31. 31.
    Daugherty A, Rateri DL, Lu H, Inagami T, Cassis LA. Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor. Circulation. 2004;110:3849–57.CrossRefPubMedGoogle Scholar
  32. 32.
    Pomaro DR, Ihara SSM, Pinto LESA, Ueda I, Casarini DE, Ebihara F, et al. High glucose levels abolish antiatherosclerotic benefits of ACE inhibition in alloxan-induced diabetes in rabbits. J Cardiovasc Pharmacol. 2005;45:295–300.CrossRefPubMedGoogle Scholar
  33. 33.
    Fonseca F, Ihara S, Izar M, et al. Hydrochlorothiazide abolishes the antiatherosclerotic effect of quinapril. Clin Exp Pharmacol Physiol. 2003;30:779–85.CrossRefPubMedGoogle Scholar

Copyright information

© Research Society for Study of Diabetes in India 2015

Authors and Affiliations

  1. 1.Functional Foods, Nutraceuticals and Phytomedicine Unit, Department of BiochemistryFederal University of Technology, AkureAkureNigeria

Personalised recommendations